chemo brain fog and cognitive issues cognify


Original video found at https://www.youtube.com/watch?v=-V3FMSNUNWQ.memory and concentration problems that can occur during, and after, cancer treatment. Chemo brain can also be called chemo fog, Mild Cognitive Impairment (MCI), or chemotherapy-related cognitive dysfunction. Cognify is the world’s first product designed specifically to alleviate chemo brain (chemo fog) signs and symptoms.Doctors used to dismiss patients who complained of brain fog. Why post-chemotherapy brain function issues are so highly varied is the “million-dollar question,” Meadows said. She and other.Though patients and survivors often complain of chemo brain during and after treatment for cancer, a growing body of research shows that there are multiple causes behind the cognitive decline many survivors experience. Whatever the culprits, cognitive complaints persist for many cancer survivors.Chemotherapy and radiation therapy can cause problems with cognitive (mental) functions, such as concentration, memory and the ability to multitask. Most chemotherapy patients experience these effects, sometimes referred to as "chemobrain" or brain fog, to some degree, although doctors are unable to predict who might be affected.Dr. Ahles has also investigated potential genetic markers for increased vulnerability to cognitive impairment after cancer treatment, including a form (or allele) of the APOE gene called 4, which is associated with Alzheimer’s disease. Other studies have shown that breast cancer survivors who have a variant of the COMT gene, which influences how quickly the brain metabolizes dopamine, are at.Chemo Brain and Chemo Fog Cognitive Assessment The assessment for cognitive deterioration following chemotherapy, or chemo brain, was designes by professionals and patients to detect the level of cognitive deterioration. After undergoing chemotherapy, it is possible for some cognitive side effects to appear, which will affect the patient’s day-to-day life.Post-chemotherapy cognitive impairment (pcci) (also known in the scientific community as "CRCIs or Chemotherapy-Related Cognitive Impairments" and in lay terms as chemotherapy-induced cognitive dysfunction or impairment, chemo brain, or chemo fog) describes the cognitive impairment that can result from chemotherapy treatment."Chemo Brain" and Alzheimer’s Risk November 23, 2016. The condition is commonly called "chemo brain" or "chemo fog", even though chemotherapy is unlikely the sole cause of these cognitive problems. The duration of chemo brain can vary from a few weeks to several years .